Brief: Processa Pharmaceuticals Says On Sept 19, Got Notice Of Delisting Or Failure To Satisfy A Continued Listing Rule Or Standard From Nasdaq
21/09/2023 22:41
Sept 21 (Reuters) - Processa Pharmaceuticals Inc
PCSA.O :
* PROCESSA PHARMACEUTICALS INC - ON SEPT 19, GOT NOTICE OF
DELISTING OR FAILURE TO SATISFY A CONTINUED LISTING RULE OR
STANDARD FROM NASDAQ
* PROCESSA PHARMACEUTICALS: GOT LETTER FROM NASDAQ NOTIFYING
CO IS
ELIGIBLE FOR SECOND 180-DAY PERIOD/UNTIL MARCH 18, 2024 TO
REGAIN COMPLIANCE
Further company coverage: PCSA.O
(Reuters.Briefs@thomsonreuters.com)